3533 POSTER Cetuximab plus Gemcitabine/Oxaliplatin (GEMOXCET) in 1st line metastatic pancreatic cancer–amulticenter phase II study

European Journal of Cancer Supplements
September 1, 2007
Cited by 14

Abstract


Related Papers

No related papers found

Powered by citation graph analysis